LDS/Medical Tests/Phenytoin, Free, Serum

Phenytoin, Free, Serum

Phenytoin is widely used to control epilepsy (seizures). It is most effective for grand mal (tonic-clonic), cortical focal, and temporal lobe seizures. It has also been used to treat myocardial arrhythmia (irregular heartbeat). It is often preferred over other antiepileptic drugs (AEDs) because it lacks the hypnotic properties seen with many other widely used AEDs. 80 – 95% of the drug is found bound to albumin. Only the unbound drug is pharmacologically active.

Phenytoin is metabolized by the liver, and has a half-life between 20 and 40 hours. Like other AEDs, phenytoin induces production of liver enzymes which metabolize it. Thus it will tend to enhance the metabolism of other drugs including carbamazepine (Tegretol), phenobarbital, acetaminophen (Tylenol), vitamins, and some oral contraceptives. The increased metabolism will decrease the effectiveness of these drugs as a result. Carbamazepine (Tegretol), phenobarbital, and alcohol have been shown to decrease the effectiveness of phenytoin because they also cause an increase in metabolic liver enzyme production. Valproic acid (Depakote), and aspirin also tend to decrease the effectiveness of phenytoin because both drugs have a greater affinity for protein binding sites. When used to treat epilepsy the therapeutic effects are seen when serum levels are generally 10 – 20 mcg/mL. Toxicity is seen when serum level reach 40 mcg/mL. Toxic side effects include lethargy, body tremors, ataxia (involuntary muscle movements), and nystagmus (uncontrollable eye movements).

  • Monitoring useful when:
  • Monitor patients receiving Phenytoin therapy
  • Aid in diagnosing/monitor Phenytoin overdose and prevention of Phenytoin toxicity

Present in:

  • Patients taking Phenytoin
  • Patients overdosed with Phenytoin

Absent in:

  • Not taking phenytoin (expected to take phenytoin)

Therapeutic concentration:  10-20 µg/mL (40-79 µmol/L)
Free phenytoin: 1-2.5 µg/mL (4-10 µmol/L)
Toxic concentration:   >30 µg/mL (120 µmol/L)

Enzyme immunoassay (EIA), Fluorescent Polarized immunoassay (FPIA), High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC).

Serum (Red top) preferred. Plasma EDTA (Lavender),or Heparin (Green). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Free Phenytoin, Hepatic function tests, CBC, Renal function tests.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Ann Neurol. 2011 Jan 19. doi: 10.1002/ana.22229. PMID: 21246600
  • Clin Pharmacokinet. 2011 Feb 1;50(2):75-80 PMID: 21241069.
  • Bishop ML, Duben-Engelkirk JL, Fody EP. Clinical Chemistry Principles, Procedures, Correlations. Philadelphia. Lippincott (1996).
  • Lehmann CA. Saunders Manual of Clinical Laboratory Science. Philadelphia. W.B. Saunders Company (1998)
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757